Track biotech stocks in clinical trials, FDA approvals, IPOs, and market shifts — in one place.
Read our latest weekly publication
Statmint is a data-forward healthcare intelligence platform. It consolidates biotech stock insights, IPOs, and drug development milestones into one research-grade source. We also publish weekly healthcare market summaries every Sunday.
Our content is tailored to biotech and pharma — from preclinical pipelines to post-market IPO moves.
We simplify clinical complexity into readable insights and make trends visible through clear visualizations.
Statmint is built to be accessible for students, analysts, and public market professionals alike.
FDA fast tracks, IPO surges, and clinical trial movements.
Read Issue